Dmitrijs Rots

611 total citations
30 papers, 181 citations indexed

About

Dmitrijs Rots is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dmitrijs Rots has authored 30 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Genetics and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dmitrijs Rots's work include Hereditary Neurological Disorders (6 papers), Acute Lymphoblastic Leukemia research (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Dmitrijs Rots is often cited by papers focused on Hereditary Neurological Disorders (6 papers), Acute Lymphoblastic Leukemia research (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Dmitrijs Rots collaborates with scholars based in Latvia, Netherlands and United Kingdom. Dmitrijs Rots's co-authors include Linda Gailīte, Nataļja Kurjāne, Baiba Lāce, Kaj Blennow, Henrik Zetterberg, Ieva Mičule, Joel Simrén, Nicholas J. Ashton, Ludmila Voložonoka and Dace Rezeberga and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Dmitrijs Rots

26 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dmitrijs Rots Latvia 8 75 37 34 34 27 30 181
Huasheng Yang China 10 54 0.7× 41 1.1× 13 0.4× 57 1.7× 12 0.4× 24 281
Borahm Kim South Korea 11 83 1.1× 37 1.0× 16 0.5× 16 0.5× 21 0.8× 21 289
Audrey Giocanti‐Auregan France 14 84 1.1× 18 0.5× 14 0.4× 19 0.6× 10 0.4× 73 572
Ken Saida Japan 10 114 1.5× 15 0.4× 26 0.8× 18 0.5× 18 0.7× 37 275
Britta Kluge Germany 11 182 2.4× 15 0.4× 30 0.9× 33 1.0× 26 1.0× 12 315
Michael Gelsomino United States 9 59 0.8× 24 0.6× 37 1.1× 89 2.6× 26 1.0× 28 269
Naama Orenstein Israel 10 103 1.4× 10 0.3× 21 0.6× 50 1.5× 31 1.1× 31 311
Jeremy Klein United States 7 68 0.9× 32 0.9× 12 0.4× 10 0.3× 11 0.4× 12 236
Ge Jia China 11 67 0.9× 20 0.5× 42 1.2× 101 3.0× 20 0.7× 22 297
Güven Toksoy Türkiye 12 185 2.5× 22 0.6× 12 0.4× 25 0.7× 57 2.1× 51 353

Countries citing papers authored by Dmitrijs Rots

Since Specialization
Citations

This map shows the geographic impact of Dmitrijs Rots's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitrijs Rots with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitrijs Rots more than expected).

Fields of papers citing papers by Dmitrijs Rots

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitrijs Rots. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitrijs Rots. The network helps show where Dmitrijs Rots may publish in the future.

Co-authorship network of co-authors of Dmitrijs Rots

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitrijs Rots. A scholar is included among the top collaborators of Dmitrijs Rots based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitrijs Rots. Dmitrijs Rots is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gailīte, Linda, et al.. (2025). Evaluating plasma biomarkers NfL, GFAP, GDF15, and FGF21 as indicators of disease severity in Charcot–Marie Tooth patients. Frontiers in Neurology. 15. 1490024–1490024. 1 indexed citations
2.
Gailīte, Linda, et al.. (2025). Metabolomics insights into Charcot–Marie–Tooth disease: toward biomarker discovery. Frontiers in Neurology. 16. 1543547–1543547.
3.
Voložonoka, Ludmila, Zita Krūmiņa, Dmitrijs Rots, et al.. (2024). Unravelling the genetic landscape of cervical insufficiency: Insights into connective tissue dysfunction and hormonal pathways. PLoS ONE. 19(9). e0310718–e0310718.
4.
Rots, Dmitrijs, et al.. (2024). Exploring disease-specific metabolite signatures in hereditary angioedema patients. Frontiers in Immunology. 15. 1324671–1324671. 1 indexed citations
5.
Gailīte, Linda, et al.. (2024). Hereditary or acquired? Comprehensive genetic testing assists in stratifying angioedema patients. Allergy Asthma and Clinical Immunology. 20(1). 1 indexed citations
6.
Awamleh, Zain, Sanaa Choufani, Wendy Wu, et al.. (2024). A new blood DNA methylation signature for Koolen-de Vries syndrome: Classification of missense KANSL1 variants and comparison to fibroblast cells. European Journal of Human Genetics. 32(3). 324–332. 1 indexed citations
7.
Rots, Dmitrijs, et al.. (2023). Prevalence of polyneuropathies among systemic sclerosis patients and impact on health-related quality of life. Neurologia i Neurochirurgia Polska. 57(2). 206–211. 4 indexed citations
8.
Kurjāne, Nataļja, et al.. (2023). Plasma neurofilament light chain level is not a biomarker of Charcot–Marie–Tooth disease progression: Results of 3‐year follow‐up study. European Journal of Neurology. 30(8). 2453–2460. 9 indexed citations
10.
Rots, Dmitrijs, et al.. (2023). National survey on clinical and genetic characteristics of patients with hereditary angioedema in Latvia. Allergy Asthma and Clinical Immunology. 19(1). 28–28. 6 indexed citations
11.
Vilne, Baiba, et al.. (2023). Genetic Basis of Early Onset Atrial Fibrillation in Patients without Risk Factors. Journal of Cardiovascular Development and Disease. 10(3). 104–104. 3 indexed citations
12.
Rots, Dmitrijs, et al.. (2023). The most common European HINT1 neuropathy variant phenotype and its case studies. Frontiers in Neurology. 14. 1084335–1084335. 1 indexed citations
13.
Šablauskas, Karolis, Wouter Steyaert, Michael Kwint, et al.. (2022). DeNovoCNN: a deep learning approach to de novo variant calling in next generation sequencing data. Nucleic Acids Research. 50(17). e97–e97. 11 indexed citations
15.
Rots, Dmitrijs, Joel Simrén, Nicholas J. Ashton, et al.. (2020). Plasma neurofilament light chain as a potential biomarker in Charcot‐Marie‐Tooth disease. European Journal of Neurology. 28(3). 974–981. 37 indexed citations
16.
Gailīte, Linda, et al.. (2020). UGT1A1 Variants c.864+5G>T and c.996+2_996+5del of a Crigler-Najjar Patient Induce Aberrant Splicing in Minigene Assays. Frontiers in Genetics. 11. 169–169. 9 indexed citations
17.
18.
Gailīte, Linda, et al.. (2018). Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome. BMC Pediatrics. 18(1). 317–317. 8 indexed citations
19.
Gailīte, Linda, et al.. (2016). Analysis of possible genetic risk factors contributing to development of childhood acute lymphoblastic leukaemia in the Latvian population. Archives of Medical Science. 3(3). 479–485. 19 indexed citations
20.
Rots, Dmitrijs, et al.. (2014). Lack of Association between Polymorphisms in Genes MTHFR and MDR1 with Risk of Childhood Acute Lymphoblastic Leukemia. Asian Pacific Journal of Cancer Prevention. 15(22). 9707–9711. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026